The results presented here generate a direct link between LOXL2-governed ECM crosslinking and the impaired accessibility and scar-degrading activity of Ly6Chi monocyte-derived MoMFs in the context of liver fibrosis. Here, LOXL2 is linked to Hepatic fibrosis.